跳至主要内容
临床试验/NCT02889627
NCT02889627招募中2 期

Efficacy and Safety of Fecal Microbiota Transplantation for Epilepsy

The Second Hospital of Nanjing Medical University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2016年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
50
试验地点
1
主要终点
Frequency of the seizures

研究概览

简要总结

Increasing evidences showed the microbiota effects on neuropsychiatric disorders. This clinical trial aims to evaluate the efficacy and safety of fecal microbiota transplantation for epilepsy.

详细描述

Very few literatures reported the clinical use of microbiota or bacteria for brain diseases. The most effective strategy for reconstruction of gut microbiota should be fecal microbiota transplantation (FMT). This study aims to evaluate the efficacy and safety of FMT for epilepsy. Patients were diagnosed as epilepsy by electroencephalogram (EEG) and MRI and clinical data when the study began and thent received repeated FMT with fecal from healthy donors.The antiepileptic medication regimen of patients remained unchanged after FMT. The primary outcome measure was the frequency of the seizures. Secondary outcome measure were the 50% response rate.

.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
3 Years 至 60 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • had been diagnosed with epilepsy for at least three months; experienced at least one seizure during the three months before WMT ;

排除标准

  • had other severe diseases, including other intestinal disorders (e.g., Clostridioides difficile infection), malignant neoplasm, cardiopulmonary failure or serious liver or kidney disease, had undergone previous FMT or WMT, had taken antibiotics within three months before starting WMT

研究组 & 干预措施

FMT with microbiota suspension

Experimental

Participants undergo repeated FMT with ~50ml microbiota suspension.

干预措施: Fecal microbiota suspension (Drug)

结局指标

主要结局

Frequency of the seizures

时间窗: 3months

the rates of patients who achieved a ≥50% reduction in seizure frequency from baseline to one month after WMT

次要结局

  • gut microbiota analysis(baseline, 1 week-post-FMT, 1 months-post-FMT, 3 months-post-FMT)
  • Adverse events(3months)

研究者

发起方
The Second Hospital of Nanjing Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Faming Zhang

Associate professor, Gastroenterology

The Second Hospital of Nanjing Medical University

研究点 (1)

Loading locations...

相似试验